STOCK TITAN

Senseonics Form 4 Filings

SENS NASDAQ

Every Form 4 that Senseonics (SENS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow SENS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SENS filings page.

Rhea-AI Summary

Senseonics Holdings, Inc. (SENS) director Douglas A. Roeder reported an open-market purchase of 13,953.2843 shares of common stock on 2026-08-19 at a weighted average price of $8.98 per share, in multiple trades between $8.95 and $8.99. Following this transaction, he directly holds 171,191.2843 shares.

Rhea-AI Summary

Prince Douglas S reported acquisition or exercise transactions in this Form 4 filing.

Senseonics Holdings, Inc. director Douglas S. Prince received a grant of 1,515 shares of common stock. This stock was issued under the company’s non-employee director compensation policy in lieu of quarterly cash retainer fees. The grant value equaled $8,120.40, based on a $5.36 closing share price. Following this award, Prince directly holds 69,331 shares of Senseonics common stock.

Rhea-AI Summary

ROEDER DOUGLAS A reported acquisition or exercise transactions in this Form 4 filing.

Senseonics Holdings director Douglas A. Roeder received a stock award of 2,751 common shares as compensation. The grant was made in lieu of quarterly cash retainer fees and was valued at $14,745.36, based on a $5.36 closing share price on July 1, 2026.

After this non‑market grant, Roeder directly holds 157,238 shares of Senseonics common stock, reflecting routine director compensation rather than an open-market purchase or sale.

Rhea-AI Summary

Fiorentino Edward reported acquisition or exercise transactions in this Form 4 filing.

Senseonics Holdings, Inc. director Edward Fiorentino received a grant of common stock as part of his non-employee director compensation. He was issued 2,635 shares of common stock in lieu of quarterly cash retainer fees, based on a value of $14,123.60 at a price of $5.36 per share, which was the closing price on July 1, 2026. Following this award, he directly owns 85,974 shares of Senseonics common stock.

Rhea-AI Summary

Senseonics Holdings director Steven Edelman received a stock grant as part of his board compensation. He acquired 2,402 shares of common stock on July 1, 2026 at a reference price of $5.36 per share, issued under the company’s non-employee director compensation policy in lieu of quarterly cash retainer fees.

The grant value was $12,874.72, based on the Nasdaq Global Select Market closing price on that date. Following this award, Edelman directly holds 91,083 shares of Senseonics common stock, reflecting routine equity-based director compensation rather than an open-market purchase.

Rhea-AI Summary

Senseonics Holdings, Inc. Chief Medical Officer Francine Kaufman reported a routine share disposition related to taxes. On the vesting of restricted stock units, 4,010 shares of common stock were withheld at a reference value of $7.18 per share to satisfy withholding tax obligations. After this tax-withholding event, Kaufman directly holds 177,057 shares of Senseonics common stock. This transaction does not represent an open-market purchase or sale, but an automatic mechanism to cover taxes tied to equity compensation.

Rhea-AI Summary

Senseonics Holdings, Inc. Chief Operating Officer Mukul Jain reported a routine tax-related share disposition. On the Form 4, 16,194 shares of common stock at a value of $7.18 per share were withheld to satisfy withholding tax obligations when restricted stock units vested, rather than sold in the open market.

After this withholding, Jain directly holds 500,863 shares of Senseonics common stock. The transaction reflects compensation-related tax withholding and does not represent an open-market purchase or sale decision.

Rhea-AI Summary

Senseonics Holdings, Inc. Chief Financial Officer Frederick T. Sullivan reported a routine tax-related share disposition. On the vesting of restricted stock units, 5,397 shares of common stock were withheld to satisfy withholding tax obligations, rather than sold on the open market.

After this tax-withholding disposition, Sullivan directly holds 226,477 shares of common stock. The filing reflects compensation-related share vesting mechanics, not an active purchase or sale decision in the market.

Rhea-AI Summary

Senseonics Holdings, Inc. reported that GC & Corp. Development Advisor Kenneth L. Horton had 9,545 shares of common stock withheld on June 15, 2026 to cover tax obligations from vesting restricted stock units. After this tax-withholding event, he directly holds 285,512 common shares.

Rhea-AI Summary

Senseonics Holdings, Inc. reported an insider equity update for Chief Commercial Officer Brian B. Hansen. On the reported date, 5,420 shares of common stock were disposed of at $7.18 per share to satisfy withholding tax obligations tied to vesting restricted stock units. This was a tax-withholding transaction rather than an open-market sale. After this event, Hansen directly owned 126,937 shares of Senseonics common stock.

Rhea-AI Summary

Senseonics Holdings, Inc. reported an insider equity transaction by President and CEO Timothy T. Goodnow. On the reported date, 32,598 shares of common stock were withheld at a price of $7.18 per share to cover withholding tax obligations tied to the vesting of restricted stock units. This was not an open-market sale but a tax-withholding disposition. After this transaction, Goodnow directly held 1,143,748 shares of Senseonics common stock.

Rhea-AI Summary

Senseonics Holdings, Inc. reported that Chief Medical Officer Francine Kaufman received equity-based compensation on May 19, 2026. She was granted 63,177 restricted stock units, each representing a contingent right to one share of common stock. Following this grant, she holds 181,067 common shares directly.

She was also awarded an employee stock option for 86,935 shares of common stock at an exercise price of $5.54 per share, expiring on May 18, 2036. The RSUs vest in eight equal installments beginning June 15, 2026, while the options vest in 48 equal monthly installments starting May 19, 2026, in each case subject to her continued service.

Rhea-AI Summary

Senseonics Holdings, Inc. reported that GC & Corp. Development Advisor Kenneth L. Horton received equity awards as part of his compensation. He was granted 157,943 restricted stock units (RSUs), each representing a right to receive one share of common stock. These RSUs vest in eight equal installments, starting on June 15, 2026, with the remaining seven installments vesting every six months beginning November 15, 2026, contingent on his continuous service.

Horton was also granted 217,338 employee stock options to buy common stock at an exercise price of $5.54 per share, expiring on May 18, 2036. These options vest in 48 equal monthly installments beginning on May 19, 2026, also subject to continued service. After these awards, he directly holds 295,057 shares of common stock and 217,338 options.

Rhea-AI Summary

Senseonics Holdings, Inc. Chief Operating Officer Mukul Jain reported equity awards consisting of restricted stock units and stock options. He received 270,759 RSUs, each representing one share of common stock, and 372,579 employee stock options with an exercise price of $5.54 per share.

The RSUs vest in eight equal installments, starting on June 15, 2026, then every six months beginning November 15, 2026, subject to his continued service. The options vest in 48 equal monthly installments beginning May 19, 2026 and expire on May 18, 2036, also contingent on continued service. After the RSU grant, Jain directly holds 517,057 shares of common stock.

Rhea-AI Summary

Senseonics Holdings director Stephen P. DeFalco received new equity awards. He was granted 9,852 shares of common stock as a restricted stock unit award with no cash paid per share. Following this grant, he directly holds 111,019 common shares.

He was also granted stock options covering 13,574 shares of common stock at an exercise price of $5.71 per share, expiring on May 19, 2036. Both the RSUs and options vest in full on the earlier of the one-year anniversary of the grant date or the next annual stockholders meeting, subject to his continuous service. The reported numbers reflect a prior 1-for-20 reverse stock split effective October 17, 2025.

Rhea-AI Summary

Senseonics Holdings, Inc. director Steven Edelman received equity compensation on a grant date of May 20, 2026. He was awarded 9,852 shares of common stock in the form of restricted stock units under the company’s non-employee director compensation policy. These RSUs vest in full on the earlier of one year from grant or the next annual stockholders meeting, provided he remains in continuous service, and each RSU converts into one share of common stock. He was also granted stock options for 13,574 shares of common stock at an exercise price of $5.71 per share, vesting on the same schedule and expiring on May 19, 2036. Following the RSU grant, he directly holds 88,681 shares of common stock.

Rhea-AI Summary

Senseonics Holdings director Edward Fiorentino received new equity awards as part of the company’s non-employee director compensation policy. He was granted 9,852 restricted stock units, each representing a contingent right to one share of common stock, vesting in full on the earlier of the one-year anniversary of the grant date or the next annual stockholders meeting, subject to his continuous service. He also received a stock option covering 13,574 shares of common stock at an exercise price of $5.71 per share, with the same vesting schedule. Following these awards, Fiorentino directly holds 83,339 shares of common stock and 13,574 stock options.

Rhea-AI Summary

Senseonics Holdings director Sharon Larkin received new equity awards as part of the company’s non-employee director compensation policy. She was granted 9,852 restricted stock units, each representing one share of common stock, and 13,574 stock options with an exercise price of $5.71 per share expiring on May 19, 2036. The RSUs and options vest in full on the earlier of one year from grant or the next annual stockholders meeting, subject to her continuous service. Following the stock award, she directly holds 41,862 shares of common stock.

Rhea-AI Summary

Senseonics Holdings, Inc. director Douglas S. Prince received equity compensation in the form of restricted stock units and stock options. He was granted 9,852 RSUs, each representing one share of common stock, and a stock option for 13,574 shares at an exercise price of $5.71 per share.

The RSUs and options were granted under the company’s non-employee director compensation policy and vest in full on the earlier of one year from grant or the next annual stockholders meeting, subject to his continuous service. Following these awards, he directly holds 67,816 shares of common stock and 13,574 options.

Rhea-AI Summary

Senseonics Holdings, Inc. director Douglas A. Roeder reported equity compensation grants consisting of restricted stock units and stock options. He received 9,852 RSUs, each representing one share of common stock, and a stock option for 13,574 shares at an exercise price of $5.7100 per share. Both awards vest in full on the earlier of the one-year anniversary of the grant date or the next annual stockholders meeting, subject to his continuous service. Following the RSU grant, Roeder directly holds 154,487 shares of common stock, and the new option award expires on May 19, 2036.

Rhea-AI Summary

Senseonics Holdings, Inc. reported that Chief Financial Officer Frederick T. Sullivan received equity compensation consisting of restricted stock units and stock options. He was granted 90,253 RSUs, each representing a right to receive one share of common stock.

The RSUs vest in eight equal installments, starting on June 15, 2026, with remaining installments every six months beginning November 15, 2026, subject to his continuous service. Sullivan also received 124,193 employee stock options with an exercise price of $5.54 per share, vesting in 48 equal monthly installments beginning May 19, 2026 and expiring on May 18, 2036. Following the RSU grant, he holds 231,874 common shares directly.

Rhea-AI Summary

Senseonics Holdings, Inc. Chief Commercial Officer Brian B. Hansen reported equity awards consisting of restricted stock units and stock options. He received 90,253 RSUs, each representing one share of common stock, bringing his direct common stock holdings to 132,357 shares after the grant.

He was also granted 124,193 employee stock options with an exercise price of $5.54 per share, all held directly, with 124,193 options outstanding after the award. The RSUs vest in eight equal installments starting on June 15, 2026, then every six months from November 15, 2026. The options vest in 48 equal monthly installments starting on May 19, 2026. All share amounts reflect a 1-for-20 reverse stock split effective October 17, 2025.

Rhea-AI Summary

Senseonics Holdings, Inc. President and CEO Timothy T. Goodnow reported receiving equity awards consisting of restricted stock units and stock options. He was granted 553,701 RSUs, each representing one share of common stock, which vest in eight equal installments starting on June 15, 2026 and then every six months beginning November 15, 2026, subject to continued service.

Goodnow was also granted 761,923 employee stock options to purchase common stock at an exercise price of $5.54 per share, vesting in 48 equal monthly installments beginning on May 19, 2026 and expiring on May 18, 2036, also contingent on continued service. Following the RSU grant, his reported direct common stock holdings total 1,176,346 shares.

Rhea-AI Summary

Senseonics Holdings, Inc. Chief Financial Officer reports routine tax withholding on vested stock units. On the reported date, Frederick T. Sullivan had 9,005 shares of common stock withheld at $5.82 per share to cover withholding tax obligations tied to the vesting of restricted stock units. These are not open-market sales, but shares retained by the company for tax payment. After this transaction, he directly holds 141,621 shares of Senseonics common stock.

Rhea-AI Summary

Senseonics Holdings, Inc. director and Chief Medical Officer Francine Kaufman reported a tax-related share disposition tied to equity compensation. On this Form 4, 6,058 shares of common stock were withheld at $5.82 per share to cover withholding tax obligations upon the vesting of restricted stock units. After this withholding, Kaufman directly holds 117,890 shares of Senseonics common stock.

Rhea-AI Summary

Senseonics Holdings Chief Operating Officer Mukul Jain reported a routine tax-related share withholding. On the vesting of restricted stock units, 13,681 shares of common stock were withheld at $5.82 per share to satisfy withholding tax obligations. Following this non-market transaction, he directly holds 246,298 shares of Senseonics common stock.

Rhea-AI Summary

Senseonics Holdings, Inc. President and CEO Timothy T. Goodnow reported a routine tax-related share disposition. On the vesting of restricted stock units, 28,598 shares of common stock were withheld at $5.82 per share to cover withholding tax obligations. After this transaction, he directly holds 622,645 shares of Senseonics common stock.

Rhea-AI Summary

Senseonics Holdings, Inc. reported that GC & Corp. Development Advisor Kenneth L. Horton had 7,320 shares of common stock withheld on May 15, 2026 to cover withholding tax obligations from vesting restricted stock units. After this tax-withholding disposition, he directly holds 137,114 shares of Senseonics common stock.

Rhea-AI Summary

Senseonics Holdings director Douglas A. Roeder bought additional shares of the company’s common stock in an open-market transaction. On this trade, he purchased 22,686 shares at a price of $5.56 per share. After the transaction, he directly holds 144,635 shares of Senseonics common stock.

Rhea-AI Summary

ROEDER DOUGLAS A reported acquisition or exercise transactions in this Form 4 filing.

Senseonics Holdings director Douglas A. Roeder received 2,218 shares of common stock as a grant in lieu of cash board fees. The shares were valued at $6.65 each, matching the Nasdaq closing price on April 1, 2026, for a total of $14,749.70 in compensation value.

This was a compensation-related award under the company’s non-employee director compensation policy, not an open-market purchase. After this grant, Roeder directly holds 121,949 shares of Senseonics common stock.

Rhea-AI Summary

Prince Douglas S reported acquisition or exercise transactions in this Form 4 filing.

Senseonics Holdings, Inc. director Douglas S. Prince received 1,221 shares of common stock on April 1, 2026 as a grant. The shares were issued under the non-employee director compensation policy in lieu of quarterly retainer fees, based on $8,119.65 divided by the $6.65 closing price. Following this award, he directly holds 57,964 common shares.

Rhea-AI Summary

Fiorentino Edward reported acquisition or exercise transactions in this Form 4 filing.

Senseonics Holdings, Inc. reported that director Edward Fiorentino received a grant of common stock as board compensation. On April 1, 2026, he was issued 2,124 shares under the non-employee director compensation policy in lieu of a $14,124.60 quarterly cash retainer at $6.65 per share. Following this award, he directly holds 73,487 shares of Senseonics common stock.

Rhea-AI Summary

Steven Edelman reported acquisition or exercise transactions in this Form 4 filing.

Senseonics Holdings director Steven Edelman received a stock grant as part of his board compensation. He was awarded 1,936 shares of common stock, valued at $12,874.40 based on a $6.65 closing price on April 1, 2026, in lieu of quarterly cash retainer fees.

Following this grant, Edelman directly holds 78,829 shares of Senseonics common stock. This was a compensation-related award rather than an open-market purchase or sale, and no derivative securities are reported in this filing.

Rhea-AI Summary

Senseonics Holdings, Inc. director Douglas A. Roeder purchased additional company stock in the open market. On March 13, 2026, he bought 17,500 shares of common stock at $5.73 per share. Following this transaction, his direct ownership increased to 119,731 shares, reflecting a meaningful personal investment in the company.

Rhea-AI Summary

Senseonics Holdings, Inc. President and CEO Timothy T. Goodnow made an open-market purchase of common stock. On March 13, 2026, he bought 17,225 shares at a weighted average price of $5.79 per share, bringing his direct ownership to 651,243 shares after the transaction.

Rhea-AI Summary

Senseonics Holdings, Inc. reported an insider equity transaction by its Chief Financial Officer, Frederick T. Sullivan. On 11/15/2025, 6,402 shares of common stock were disposed of at a price of $6.26 per share in a transaction coded "F," which indicates shares were withheld to cover tax obligations on vesting restricted stock units. After this tax withholding, Sullivan beneficially owned 150,626 shares of Senseonics common stock in direct ownership. This type of transaction reflects administrative share withholding rather than an open-market sale.

Rhea-AI Summary

Senseonics Holdings, Inc. insider reports routine share withholding for taxes. A director and Chief Medical Officer filed a Form 4 showing the disposition of 4,605 shares of common stock on 11/15/2025 at $6.26 per share, coded as an "F" transaction, meaning shares were withheld to cover tax obligations upon vesting of restricted stock units. After this transaction, the insider beneficially owned 123,948 shares of Senseonics common stock. The company effected a 1-for-20 reverse stock split of its common stock effective October 17, 2025, and the share amounts reported in this filing have been adjusted to reflect that reverse split.

Rhea-AI Summary

Senseonics Holdings, Inc. (SENS) reported an insider equity transaction by its Chief Operating Officer on a Form 4. On 11/15/2025, 10,317 shares of common stock were withheld and disposed of at $6.26 per share to cover withholding tax obligations tied to the vesting of restricted stock units. After this tax-related transaction, the reporting person beneficially owned 259,979 shares of common stock directly. The company also notes that, effective October 17, 2025, it implemented a 1-for-20 reverse stock split, and all share amounts in the report have been adjusted to reflect this reverse split.

Rhea-AI Summary

Senseonics Holdings, Inc. (SENS) reported an insider equity transaction by its GC & Corp. Development Advisor on a Form 4. On 11/15/2025, 5,997 shares of common stock were withheld at $6.26 per share to cover withholding taxes upon the vesting of restricted stock units. Following this transaction, the reporting person beneficially owned 144,434 shares of common stock in direct ownership form.

The filing also notes that, effective October 17, 2025, Senseonics implemented a 1-for-20 reverse stock split of its common stock, and the share numbers in the report have been adjusted to reflect this reverse split.

Rhea-AI Summary

Senseonics Holdings, Inc. (SENS) reported an insider equity transaction by its President and CEO, who is also a director. On 11/15/2025, the executive disposed of 27,067 shares of common stock at $6.26 per share, coded "F" for a tax-related withholding event.

After this transaction, the executive directly beneficially owned 634,018 shares of Senseonics common stock. The filing explains that the shares were withheld to satisfy withholding tax obligations upon the vesting of restricted stock units, meaning the disposition was tied to equity-compensation taxation rather than an open-market sale.

Rhea-AI Summary

Senseonics Holdings (SENS): A company director reported an open‑market purchase of common stock on 11/10/2025. The filing shows 10,000 shares acquired at a weighted average price of $6.55, with individual trades executed between $6.48 and $6.58. Following this transaction, the director beneficially owned 74,708 shares, held directly.

The share counts reflect the issuer’s 1‑for‑20 reverse stock split that became effective on October 17, 2025.

Rhea-AI Summary

Senseonics Holdings (SENS) director reported an open‑market purchase of common stock. On 11/07/2025, the insider bought 15,000 shares at $5.83 per share (Transaction Code P). Following the trade, the insider beneficially owns 99,727 shares, held directly. A footnote states that, effective October 17, 2025, the company completed a 1‑for‑20 reverse stock split, and the reported share amounts reflect this adjustment.

Rhea-AI Summary

Senseonics Holdings (SENS): CFO insider purchase reported. The Chief Financial Officer bought 5,415 shares of common stock on 11/07/2025, reported with Transaction Code P. The weighted average purchase price was $5.88 per share, from multiple trades ranging from $5.8401 to $5.885.

Following the transaction, the reporting person beneficially owns 157,028 shares, held directly. The share counts reflect the issuer’s 1-for-20 reverse stock split effective October 17, 2025.

Rhea-AI Summary

Senseonics Holdings (SENS) reported an insider purchase on Form 4. A reporting person who serves as President, CEO, and Director bought 17,210 shares of common stock on 11/07/2025 at a weighted average price of $5.87.

Following the transaction, the filer beneficially owns 661,085 shares, held directly. The company effected a 1-for-20 reverse stock split on October 17, 2025, and the reported share amounts reflect this adjustment. The price reflects multiple trades between $5.80 and $5.90.

Rhea-AI Summary

Senseonics Holdings director Douglas S. Prince received 19,673 shares of common stock on 10/01/2025 as payment under the company’s non-employee director compensation policy in lieu of quarterly retainer fees. The shares were issued using the closing price of $0.413 on the NYSE American for that date, representing the reported cash-equivalent value of $8,124.95. After the issuance, the filing reports the reporting person beneficially owned 1,107,280 shares. The Form 4 was signed by an attorney-in-fact and filed on 10/03/2025.

Rhea-AI Summary

Douglas A. Roeder, a director of Senseonics Holdings, Inc. (SENS), received 35,714 shares of common stock under the company’s non-employee director compensation policy in lieu of quarterly cash retainer fees. The shares were issued based on the NYSE American closing price of $0.413 per share on the transaction date, representing cash-equivalent compensation of $14,749.88. After this issuance, the reporting person beneficially owned 1,694,540 shares of the issuer’s common stock. The transaction is reported on a Form 4 and was filed by a single reporting person. The Form states the issuance was pursuant to the issuer’s director compensation policy and discloses the calculation used to determine the share amount.

Rhea-AI Summary

Senseonics Holdings director Edward Fiorentino received 34,200 shares of common stock on 10/01/2025 under the company's non-employee director compensation policy. The shares were issued in lieu of a quarterly retainer; the filing states the number of shares equals $14,124.60 divided by the closing price of $0.413 per share on the NYSE American that day.

After the issuance, the reporting person beneficially owned 1,379,301 shares. The Form 4 was signed by attorney-in-fact Frederick T. Sullivan on 10/03/2025. The filing records this as a routine equity grant to a director under the disclosed compensation policy.

Rhea-AI Summary

Senseonics Holdings, Inc. disclosed an insider transaction on a Form 4 showing a director received 31,174 shares of common stock on October 1, 2025. The shares were issued under the non-employee director compensation policy in lieu of quarterly retainer fees, calculated as $12,874.86 divided by the $0.413 closing price on that date.

Following the transaction, the director beneficially owned 1,294,175 shares, held directly.